Accrued Liabilities, Current in USD of Vitro Biopharma, Inc. from Q3 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Vitro Biopharma, Inc. quarterly Accrued Liabilities, Current history and change rate from Q3 2010 to Q2 2025.
  • Vitro Biopharma, Inc. Accrued Liabilities, Current for the quarter ending 31 Jul 2025 was $1.86M, a 16.5% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1.86M +$264K +16.5% 31 Jul 2025 10-Q 12 Sep 2025
Q1 2025 $1.84M +$287K +18.5% 30 Apr 2025 10-Q 20 Jun 2025
Q4 2024 $1.86M +$353K +23.4% 31 Jan 2025 10-Q 20 Mar 2025
Q3 2024 $1.81M +$496K +37.9% 31 Oct 2024 10-Q 12 Sep 2025
Q2 2024 $1.6M 31 Jul 2024 10-Q 16 Sep 2024
Q1 2024 $1.55M +$592K +61.8% 30 Apr 2024 10-Q 31 May 2024
Q4 2023 $1.51M +$593K +65% 31 Jan 2024 10-Q 14 Mar 2024
Q3 2023 $1.31M +$371K +39.5% 31 Oct 2023 10-K 28 Jan 2025
Q1 2023 $959K 30 Apr 2023 10-Q 13 Jun 2023
Q4 2022 $913K 31 Jan 2023 10-Q 14 Mar 2023
Q3 2022 $940K 31 Oct 2022 10-Q 13 Jun 2023
Q2 2012 $2.4K -$4.35K -64.5% 31 Jul 2012 10-Q/A 17 Oct 2012
Q1 2012 $8.31K 30 Apr 2012 10-Q/A 22 Jun 2012
Q4 2011 $10.5K 31 Jan 2012 10-Q 21 Mar 2012
Q3 2011 $2.9K -$5.69K -66.2% 31 Oct 2011 10-K 12 Feb 2013
Q2 2011 $6.75K 31 Jul 2011 10-Q/A 12 Oct 2011
Q3 2010 $8.59K 31 Oct 2010 10-K/A 16 Feb 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.